Literature DB >> 2248504

Reappraisal of thyroxine treatment in primary hypothyroidism.

S Hodges1, B P O'Malley, B N Northover, K L Woods, P G Swift.   

Abstract

The optimum daily dose of thyroxine was calculated for 13 children aged 3-16 years with primary hypothyroidism by titrating their doses at monthly intervals. The condition of the thyroid was assessed by sensitive assay of thyroid stimulating hormone concentrations, as well as measurement of total and free thyroid hormone concentrations and systolic time interval ratios. Serum thyroid stimulating hormone concentration was found to be the most responsive to small changes in thyroxine. The calculated optimum daily replacement dose of thyroxine (102 micrograms/m2 or 3.5 micrograms/kg) was fractionally lower than that previously recommended, and was more closely related to surface area (coefficient of variation 8.2%) than to body weight (coefficient of variation 16.2%). Our results suggest that though monthly may be the optimal time interval for increases in the dose of thyroxine, any reduction in the dose should be made more gradually.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2248504      PMCID: PMC1792337          DOI: 10.1136/adc.65.10.1129

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

Review 1.  Thyroid hormone replacement therapy in the perinatal period: neurologic considerations.

Authors:  M E Weichsel
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

2.  Propranolol versus carbimazole as the sole treatment for thyrotoxicosis. A consideration of circulating thyroid hormone levels and tissue thyroid function.

Authors:  B P O'Malley; R J Abbott; D B Barnett; B J Northover; F D Rosenthal
Journal:  Clin Endocrinol (Oxf)       Date:  1982-06       Impact factor: 3.478

3.  Elevated threshold for thyrotropin suppression in congenital hypothyroidism.

Authors:  R M Schultz; M S Glassman; M H MacGillivray
Journal:  Am J Dis Child       Date:  1980-01

4.  Systolic time intervals: a valuable parameter of thyroid function.

Authors:  W J Paulus; R Ranquin; G Parizel
Journal:  Angiology       Date:  1980-02       Impact factor: 3.619

5.  Premature craniosynostosis-a complication of thyroid replacement therapy.

Authors:  J L Penfold; D A Simpson
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

6.  Systolic time intervals in hypothyroidism: end organ function as a reflection of clinical status.

Authors:  G D Plotnick; D L Vassar; A F Parisi; B P Hamilton; N H Carliner; M L Fisher
Journal:  Am J Med Sci       Date:  1979 May-Jun       Impact factor: 2.378

7.  Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children.

Authors:  I Rezvani; A M DiGeorge
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

8.  Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.

Authors:  T Sato; Y Suzuki; T Taketani; K Ishiguro; H Nakajima
Journal:  J Clin Endocrinol Metab       Date:  1977-03       Impact factor: 5.958

9.  Management of patients with congenital hypothyroidism.

Authors:  G J Frost; J M Parkin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

10.  Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans.

Authors:  L H Fish; H L Schwartz; J Cavanaugh; M W Steffes; J P Bantle; J H Oppenheimer
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

  10 in total
  4 in total

1.  Monitoring TSH concentrations during treatment for congenital hypothyroidism.

Authors:  D B Grant
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Increased plasma thyroid stimulating hormone in treated congenital hypothyroidism: relation to severity of hypothyroidism, plasma thyroid hormone status, and daily dose of thyroxine.

Authors:  D B Grant; P W Fuggle; I Smith
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

3.  Prediction of LT4 replacement dose to achieve euthyroidism in subjects undergoing total thyroidectomy for benign thyroid disorders.

Authors:  Ranjith Sukumar; Amit Agarwal; Sushil Gupta; Anjali Mishra; Gaurav Agarwal; A K Verma; S K Mishra
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

Review 4.  Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome.

Authors:  Joanne Rovet; Denis Daneman
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.